Skip to content

SGMO

Sangamo Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.07
+0.00%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-48.3%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
May 27, 2026Jain Nikunj · officer: Principal Accounting OfficerF-InKind1,919$0.17
May 27, 2026Macrae Sandy · director, officer: PRESIDENT, CEO AND DIRECTORF-InKind12,613$0.17
May 27, 2026Davis Gregory D · officer: Head of Research & TechnologyF-InKind1,630$0.17
May 27, 2026Willoughby Scott B. · officer: SVP, CHIEF LEGAL OFFICER, SECYF-InKind4,036$0.17
May 27, 2026Dubois-Stringfellow Nathalie · officer: SVP-CHIEF DEVELOPMENT OFFICERF-InKind4,036$0.17
Apr 23, 2026Davis Gregory D · officer: Head of Research & TechnologySale69,827$0.25
Apr 23, 2026Dubois-Stringfellow Nathalie · officer: SVP-CHIEF DEVELOPMENT OFFICERSale345,942$0.26
Apr 3, 2026Macrae Sandy · director, officer: PRESIDENT, CEO AND DIRECTORA-Award2,500,000$0.26
Apr 3, 2026Dubois-Stringfellow Nathalie · officer: SVP-CHIEF DEVELOPMENT OFFICERA-Award800,000$0.26
Apr 3, 2026Jain Nikunj · officer: Principal Accounting OfficerA-Award225,000$0.26
Apr 3, 2026Davis Gregory D · officer: Head of Research & TechnologyA-Award225,000$0.26
Apr 3, 2026Willoughby Scott B. · officer: SVP, CHIEF LEGAL OFFICER, SECYA-Award800,000$0.26
Feb 26, 2026Dubois-Stringfellow Nathalie · officer: SVP-CHIEF DEVELOPMENT OFFICERF-InKind2,063$0.47
Feb 26, 2026Dubois-Stringfellow Nathalie · officer: SVP-CHIEF DEVELOPMENT OFFICERF-InKind12,354$0.47
Feb 26, 2026Willoughby Scott B. · officer: SVP, CHIEF LEGAL OFFICER, SECYF-InKind1,650$0.47
Feb 26, 2026Macrae Sandy · director, officer: PRESIDENT, CEO AND DIRECTORF-InKind33,637$0.47
Feb 26, 2026Davis Gregory D · officer: Head of Research & TechnologyF-InKind832$0.47
Feb 26, 2026Jain Nikunj · officer: Principal Accounting OfficerF-InKind666$0.47
Feb 26, 2026Davis Gregory D · officer: Head of Research & TechnologyF-InKind5,119$0.47
Feb 26, 2026Jain Nikunj · officer: Principal Accounting OfficerF-InKind5,119$0.47
Feb 26, 2026Willoughby Scott B. · officer: SVP, CHIEF LEGAL OFFICER, SECYF-InKind12,354$0.47
Feb 26, 2026Macrae Sandy · director, officer: PRESIDENT, CEO AND DIRECTORF-InKind5,291$0.47
Jan 26, 2026Dubois-Stringfellow Nathalie · officer: SVP-CHIEF DEVELOPMENT OFFICERF-InKind36,676$0.40
Jan 26, 2026Duraibabu Prathyusha · officer: PRINCIPAL FINANCIAL OFFICERF-InKind36,676$0.40
Jan 26, 2026Davis Gregory D · officer: Head of Research & TechnologyF-InKind7,721$0.40
Jan 26, 2026Macrae Sandy · director, officer: PRESIDENT, CEO AND DIRECTORF-InKind102,950$0.40
Jan 26, 2026Jain Nikunj · officer: Principal Accounting OfficerF-InKind7,721$0.40
Jan 26, 2026Willoughby Scott B. · officer: SVP, CHIEF LEGAL OFFICER, SECYF-InKind36,676$0.40
Nov 26, 2025Dubois-Stringfellow Nathalie · officer: SVP-CHIEF DEVELOPMENT OFFICERF-InKind2,544$0.42
Nov 26, 2025Davis Gregory D · officer: Head of Research & TechnologyF-InKind723$0.42
Institutional positioning

13F filings over the trailing two quarters

New 28Increased 29Reduced 20Sold out 115
FilerActionSharesFiled
ARMISTICE CAPITAL, LLCNew Position40,400,067May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position12,704,408May 15, 2026
TWO SIGMA INVESTMENTS, LPIncreased6,270,441May 15, 2026
BALYASNY ASSET MANAGEMENT L.P.New Position5,288,097May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased4,570,862May 15, 2026
BLACKROCK, INC.Reduced4,547,848May 13, 2026
RENAISSANCE TECHNOLOGIES LLCReduced3,836,665May 14, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPReduced2,752,363May 15, 2026
UBS GROUP AGIncreased2,570,992May 5, 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INCIncreased2,352,360May 15, 2026
VANGUARD FIDUCIARY TRUST CONew Position2,310,297May 8, 2026
JACOBS LEVY EQUITY MANAGEMENT, INCIncreased2,050,384May 15, 2026
BANK OF AMERICA CORP /DE/Increased1,838,390May 18, 2026
STATE STREET CORPIncreased1,694,783May 15, 2026
LUMINUS MANAGEMENT LLCIncreased1,681,089May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 27, 2026